Targeting the TWEAK/Fn14 signalling pathway as a novel therapeutic strategy to prevent chronic liver disease progression.
GA ID:
Agency:
National Health and Medical Research Council (NHMRC)
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019
to
31-Dec-2022
Value (AUD):
$997,485.80
Recipient Name:
Curtin University
Last Updated:
21-Dec-2018 9:53 am (ACT Local Time)